Related Experiment Videos
Alteration of peripheral blood lymphocyte subsets in essential hypertension
1Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Essential hypertension (EH) is linked to significant changes in T-cell (CD3, CD4) and B-cell (CD22) populations. Blood pressure control did not alter these immune cell profiles in this study of hypertensive patients.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Hematology
Background:
- Essential hypertension (EH) is a complex condition with potential immune system involvement.
- Understanding immune cell alterations in EH may offer new therapeutic targets.
Purpose of the Study:
- To evaluate changes in lymphocytic subpopulations in patients with untreated essential hypertension.
- To determine if blood pressure control affects these immune cell alterations.
Main Methods:
- A prospective study involving 30 patients with essential hypertension (mild to severe) and 10 normotensive controls.
- Lymphocyte phenotyping (CD3, CD4, CD8, CD22) and activation marker (CD25) assays were performed using the APAAP technique before and after blood pressure control.
Main Results:
- Untreated EH patients showed decreased CD3 and CD4 T-cells and increased CD22 B-cells.
- Severe EH patients exhibited reduced CD25 expression with phytohemagglutinin stimulation.
- A negative correlation was found between CD25 and diastolic pressure.
- No significant immune cell changes were observed after two weeks of blood pressure normalization.
Conclusions:
- Untreated essential hypertension is associated with distinct alterations in lymphocyte populations.
- These immune changes may be a characteristic of the hypertensive state rather than a direct consequence of elevated blood pressure.
- Further research in larger cohorts is warranted to confirm these findings.
Objective:
To assess lymphocytic subpopulation by labelled monoclonal antibody technique in a small group of patients with untreated essential hypertension (EH) and to detect any alteration with control of blood pressure.
Design:
Prospective study with phenotypic estimation of lymphocytes at presentation and a minimum of two weeks after the control of blood pressure.
Setting:
Referral, tertiary care hospital.
Patients:
Group 1, normotensive controls (n = 10); group 2, mild to moderate essential hypertension (n = 10); group 3, severe (accelerated/malignant) hypertension (n = 10). All the secondary causes of hypertension were ruled out by a thorough history, physical examination and appropriate radiological and biochemical investigations.
Tests:
Venous blood samples, taken at entry and a minimum of two weeks after control of blood pressure, were analyzed by alkaline phosphatase antialkaline phosphatase (APAAP) antibody technique for CD4, CD3, CD8 and CD22. Peripheral lymphocytes were separated and cocultured with phytohemagglutinin (PHA) for 72 h and assayed for CD25 by the APAAP technique.
Main Results:
In untreated patients with EH (groups 2 and 3), there was a significant down regulation of CD3, and CD4 lymphocytes whereas the proportion of mature CD22 cells increased. In group 3 there was a significant down regulation of CD25 with PHA stimulation. A negative correlation was observed between CD25 and diastolic pressure upon pooling the results of groups 2 and 3. No significant alteration in these parameters was observed following control of blood pressure with drugs for up to two weeks.
Conclusion:
In this small group of patients with untreated EH, a significant alteration in the lymphocytic repertoire was observed. Whether this will be found in large groups of hypertensives remains to be seen.